西班牙风湿病学会狼疮登记(RELESSER)大型队列中1869次妊娠的妊娠结局
该多中心回顾性观察研究基于RELESSER队列,纳入809例系统性红斑狼疮(SLE)女性的1869次妊娠,其中1395次足月。SLE诊断前妊娠的足月率高于诊断后妊娠(76.8% vs 69.8%,p<0.001)。抗心磷脂IgG及抗β2糖蛋白I IgG/IgM阳性与妊娠并发症风险升高相关,而狼疮抗凝物未见差异。
要点
- SLE诊断前妊娠的足月率高于诊断后妊娠(76.8% vs 69.8%,p<0.001)。
- 有妊娠并发症者抗磷脂综合征比例更高(40.5% vs 9.9%,p<0.001)。
- 抗心磷脂IgG、抗β2糖蛋白I IgG/IgM阳性与妊娠并发症相关,狼疮抗凝物无差异。
核心结论
- SLE诊断前妊娠的足月可能性高于诊断后妊娠。
- 在该队列中,抗心磷脂IgG及抗β2糖蛋白I IgG/IgM阳性与较差的妊娠结局风险升高相关,而狼疮抗凝物与之无关。
研究设计与样本
- 多中心回顾性观察研究,基于西班牙风湿病学会狼疮登记(RELESSER)队列,随访12年。
- 纳入809例女性SLE患者,共1869次妊娠,其中1395次达到足月。
- 除登记数据外,收集产科/妇科变量及所接受治疗的数据。
- 比较SLE诊断前与诊断后妊娠的足月妊娠数,并比较诊断前后妊娠女性及有无妊娠并发症女性的临床和实验室特征。
- 采用双变量和多变量分析识别可能与妊娠并发症相关的因素。
主要发现
- SLE诊断前妊娠女性较诊断后妊娠女性有更多妊娠次数(2.37 vs 1.87)和更高的足月妊娠率(76.8% vs 69.8%,p<0.001)。
- SLE诊断前妊娠女性诊断年龄更大(43.4 vs 34.1岁)且合并症更多。
- 诊断前与诊断后妊娠组在抗体谱(包括抗dsDNA、抗Sm、抗Ro、抗La、狼疮抗凝物、抗心磷脂或抗β2糖蛋白I)方面未见差异。
- 809例女性中114例发生妊娠并发症,包括流产、子痫前期/子痫、胎儿死亡和/或早产。
- 有并发症女性抗磷脂综合征比例更高(40.5% vs 9.9%,p<0.001),IgG抗心磷脂抗体阳性率更高(33.9% vs 21.3%,p=0.005),IgG抗β2糖蛋白I抗体阳性率更高(26.1% vs 14%,p=0.007),IgM抗β2糖蛋白I抗体阳性率更高(26.1% vs 16%,p=0.032),狼疮抗凝物未见差异。
关键数值与推荐
- 足月妊娠率:SLE诊断前妊娠组76.8% vs 诊断后妊娠组69.8%(p<0.001)。
- 妊娠次数:SLE诊断前妊娠组2.37 vs 诊断后妊娠组1.87。
- 诊断年龄:SLE诊断前妊娠组43.4岁 vs 诊断后妊娠组34.1岁。
- 抗磷脂综合征比例:有妊娠并发症组40.5% vs 无并发症组9.9%(p<0.001)。
- 抗体阳性率(有并发症组 vs 无并发症组):IgG抗心磷脂33.9% vs 21.3%(p=0.005);IgG抗β2糖蛋白I 26.1% vs 14%(p=0.007);IgM抗β2糖蛋白I 26.1% vs 16%(p=0.032)。
临床怎么用
- 在所接受的治疗中,仅有肝素在有妊娠并发症的女性中更常用。
- 糖皮质激素或羟氯喹的使用未见差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Obstetric complications are more common in women with systemic lupus erythematosus (SLE) than in the general population. OBJECTIVE: To assess pregnancy outcomes in women with SLE from the RELESSER cohort after 12 years of follow-up. METHODS: A multicentre retrospective observational study was conducted. In addition to data from the RELESSER register, data were collected on obstetric/gynaecological variables and treatments received. The number of term pregnancies was compared between women with pregnancies before and after the diagnosis of SLE. Further, clinical and laboratory characteristics were compared between women with pregnancies before and after the diagnosis, on the one hand, and with and without complications during pregnancy, on the other. Bivariate and multivariate analyses were carried out to identify factors potentially associated with complications during pregnancy. RESULTS: A total of 809 women were included, with 1869 pregnancies, of which 1395 reached term. Women with pregnancies before the diagnosis of SLE had more pregnancies (2.37 vs 1.87) and a higher rate of term pregnancies (76.8% vs 69.8%, p < 0.001) compared to those with pregnancies after the diagnosis. Women with pregnancies before the diagnosis were diagnosed at an older age (43.4 vs 34.1 years) and had more comorbidities. No differences were observed between the groups with pregnancies before and after diagnosis in antibody profile, including anti-dsDNA, anti-Sm, anti-Ro, anti-La, lupus anticoagulant, anticardiolipin or anti-beta-2-glycoprotein. Overall, 114 out of the 809 women included in the study experienced complications during pregnancy, including miscarriage, preeclampsia/eclampsia, foetal death, and/or preterm birth. Women with complications had higher rates of antiphospholipid syndrome (40.5% vs 9.9%, p < 0.001) and higher rates of positivity for IgG anticardiolipin (33.9% vs 21.3%, p = 0.005), IgG anti-beta 2 glycoprotein (26.1% vs 14%, p = 0.007), and IgM anti-beta 2 glycoprotein (26.1% vs 16%, p = 0.032) antibodies, although no differences were found regarding lupus anticoagulant. Among the treatments received, only heparin was more commonly used by women with pregnancy complications. We did not find differences in corticosteroid or hydroxychloroquine use. CONCLUSIONS: The likelihood of term pregnancy is higher before the diagnosis of SLE. In our cohort, positivity for anticardiolipin IgG and anti-beta-2- glycoprotein IgG/IgM, but not lupus anticoagulant, was associated with a higher risk of poorer pregnancy outcomes.
引用
- Laíño-Piñeiro MC, Rúa-Figueroa I, Jiménez N, et al. Pregnancy outcomes in 1869 pregnancies in a large cohort from the Spanish Society of Rheumatology Lupus Register (RELESSER). Semin Arthritis Rheum. 2023. PMID: 37348350. doi:10.1016/j.semarthrit.2023.152232
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。